We have carried out the genotyping using fluorescence measurements. We used the Taqman ABI Prism 7000, Applied Biosystems, Applera, Germany GmbH, Darmstadt, with the ABI Prism 7000 sds software v1.1. In the first step, a sequence is amplified by its specific primer pair, which includes

the polymorphism. Two identification probes that are attached to the reaction mixture and which are marked with two different fluorescent dyes, bind to the polymorphism, either as a wild-type probe or as a mutated probe. In heterozygous individuals, both kinds of the probes are binding. The fluorescent dye of the appropriate probe is released if the probe is destroyed by DNA polymerase during the PCR and can be measured. The destruction Inhibitor Library molecular weight of the probe and thus the release see more of the fluorescence dye can only occur if the identification probe and the sequence match. Depending on which of the two fluorescent dyes is released, the existence of a homozygous wild type, the homozygous mutation or a heterozygous polymorphism can be identified. The reaction mixture per sample contained 7.5 μl MasterMixPuffer, consisting of buffer, dNTPs and AmpliTaq Gold® polymerase, TaqMan® SNP Genotyping Assay Set; Applied Biosystems, Darmstadt, Germany, 0.25 μl test kit (identification probes and primers), 5.25 μl aqua dest. and 2 μl DNA. The sequences of primers and identification probes are presented

in Table 1. The typification kit was manufactured by Applied Biosystems, Assays-by-design. The conditions for amplification of the IL-2 and TNF-α gene were one cycle at 50 °C for 2 min and one cycle at 95 °C for 10 min followed by 40 cycles at 95 °C (15 s)

and 60 °C (1 min). The descriptive representation of the IL-2 and TNF-α release was carried out by the arithmetic Pregnenolone mean and standard deviation. According to the level of cytokine release, we grouped the probands into high, medium and low expressor tertiles. The data were reviewed for a Gaussian distribution with the Shapiro–Wilk test. The comparison of the IL-2 and the TNF-α release between the 2000 μm glutamine-supplemented group and the 250 μm glutamine-supplemented group was made with an analysis of variance and the Scheffé test. The significance level was set at 0.05. The distribution of genotypes and the relation of the genotype with the IL-2 and TNF-α tertiles have been reviewed with the χ2 test. The IL-2 release in dependence of glutamine supplementation is shown in Table 2. According to the level of low, medium and high cytokine release, the release was scaled into high, medium and low expressor tertiles. Overall, the range of the IL-2 release in the probands whole blood samples was very wide. When analysing the different expressor tertiles individually, an average increase of 47% of cytokine release in the low expressor group was found, when glutamine was added.